8 Universal LCMS-based assay platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics using one reference antibody
Noriko Iwamoto(Shimadzu (Japan)), Takashi Shimada(Keio University), Akinobu Hamada(National Cancer Research Institute), Bernard A. Fox(Oregon Health & Science University), Yoshinobu Koguchi(Providence Portland Medical Center), Brian Piening(Providence College), Eric Tran(Providence Portland Medical Center), William L. Redmond(Providence St. Vincent Medical Center), Atsushi Yonezawa(Kyoto University Hospital), Kotoko Yokoyama(Shimadzu (Japan))
Cited by 1
Related Papers
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
|Journal of Clinical Investigation|2004|1.4k
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
Longitudinal multi-omics of host–microbe dynamics in prediabetes
|Nature|2019|620
Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape
|European Journal of Cancer|2017|565